Securing retatrutide can be a hurdle for many. Currently, it is restricted and necessitates a prescription from a medical provider. Receiving retatrutide typically involves participating in a investigative program, though potential wider release through traditional healthcare systems is being explored – though a timeframe for this remains unknown